Zeng Li Yang
Chief Executive Officer chez AUTOBIO DIAGNOSTICS CO., LTD.
Profil
Actuellement, Zeng Li Yang occupe le poste de directeur général et de directeur chez Autobio Diagnostics Co., Ltd. Il est également membre du conseil d'administration de Beijing Bio-Top Biotechnology Co. Ltd.
Postes actifs de Zeng Li Yang
| Sociétés | Poste | Début |
|---|---|---|
| AUTOBIO DIAGNOSTICS CO., LTD. | Chief Executive Officer | 29/10/2018 |
Autobio Biochemistry Co., Ltd.
 Autobio Biochemistry Co., Ltd. Medical SpecialtiesHealth Technology Beijing Bio-Top Biotechnology Co., Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostics. Its products include hydroxy vitamin D, anti cyclic citrullinated peptide, heart fatty acid binding protein, procalcitonin, neutrophil gelatinase associated lipocalin, prospepsin, cardiac troponin 1, myoglobin, nonesterified free fatty acid, and cholyglycine. The company was founded on October 20, 2009 and is headquartered in Beijing, China. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AUTOBIO DIAGNOSTICS CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Autobio Biochemistry Co., Ltd.
Autobio Biochemistry Co., Ltd. Medical SpecialtiesHealth Technology Beijing Bio-Top Biotechnology Co., Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostics. Its products include hydroxy vitamin D, anti cyclic citrullinated peptide, heart fatty acid binding protein, procalcitonin, neutrophil gelatinase associated lipocalin, prospepsin, cardiac troponin 1, myoglobin, nonesterified free fatty acid, and cholyglycine. The company was founded on October 20, 2009 and is headquartered in Beijing, China. | Health Technology |
